디지털 감산 혈관조영술과 자기 공명 혈관조영술에서 중대뇌동맥의 협착 측정을 위한 North American Symptomatic Carotid Endarterectomy Trial 및 Warfarin-Aspirin Symptomatic Intracranial Disease 방법의 비교 평가
Comparative Evaluation of North American Symptomatic Carotid Endarterectomy Trial and Warfarin-Aspirin Symptomatic Intracranial Disease Methods for Measurement of Middle Cerebral Artery Stenosis in Digital Subtraction Angiography and Magnetic Resonance Angiography
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
This study aimed to determine whether there was a difference in measurements between North American Symptomatic Carotid Endarterectomy Trial(NASCET) and Warfarin-Aspirin Symptomatic Intracranial Disease(WASID) methods that measure the middle cerebral artery stenosis in Digital Subtraction Angiography (DSA) and Magnetic Resonance Angiography (MRA). It involved 24 patients who had completed both DSA and MRA among patients with Middle Cerebral Artery (MCA) stenosis. The Middle Cerebral Artery (MCA) stenosis was measured using the NASCET and WASID methods through a retrospective analysis. For the NASCET and WASID methods, they performed measurements on normal blood vessels located far from and close to the stenosis, respectively. The mean value and standard deviation of the Digital Subtraction Angiography (DSA) measured by the NASCET method were 59.23% and 13.27%. On the other hand, those of the Digital Subtraction Angiography (DSA) measured by the WASID method were 66.64% and 12.47%. And, the mean value and standard deviation of the Magnetic Resonance Angiography (MRA) measured by the NASCET method were 49.82% and 12.06%. By contrast, those of the Magnetic Resonance Angiography (MRA) measured by the WASID method were 56.63% and 10.67%. All the p-values obtained by the Pearson and Spearman correlation tests in the Digital Subtraction Angiography (DSA) and the Magnetic Resonance Angiography (MRA) were <0.01. In conclusion, this study suggests that both the NASCET and WASID methods to measure the middle cerebral artery stenosis in the Digital Subtraction Angiography (DSA) and the Magnetic Resonance Angiography (MRA) can be used if they are not used interchangeably.
Abstract
This study aimed to determine whether there was a difference in measurements between North American Symptomatic Carotid Endarterectomy Trial(NASCET) and Warfarin-Aspirin Symptomatic Intracranial Disease(WASID) methods that measure the middle cerebral artery stenosis in Digital Subtraction Angiography (DSA) and Magnetic Resonance Angiography (MRA). It involved 24 patients who had completed both DSA and MRA among patients with Middle Cerebral Artery (MCA) stenosis. The Middle Cerebral Artery (MCA) stenosis was measured using the NASCET and WASID methods through a retrospective analysis. For the NASCET and WASID methods, they performed measurements on normal blood vessels located far from and close to the stenosis, respectively. The mean value and standard deviation of the Digital Subtraction Angiography (DSA) measured by the NASCET method were 59.23% and 13.27%. On the other hand, those of the Digital Subtraction Angiography (DSA) measured by the WASID method were 66.64% and 12.47%. And, the mean value and standard deviation of the Magnetic Resonance Angiography (MRA) measured by the NASCET method were 49.82% and 12.06%. By contrast, those of the Magnetic Resonance Angiography (MRA) measured by the WASID method were 56.63% and 10.67%. All the p-values obtained by the Pearson and Spearman correlation tests in the Digital Subtraction Angiography (DSA) and the Magnetic Resonance Angiography (MRA) were <0.01. In conclusion, this study suggests that both the NASCET and WASID methods to measure the middle cerebral artery stenosis in the Digital Subtraction Angiography (DSA) and the Magnetic Resonance Angiography (MRA) can be used if they are not used interchangeably.
참고문헌 (16)
- Weimar C, "Distribution and outcome of symptomatic stenoses and occlusions in patients with acute cerebral ischemia", Archives of Neurology, 63(9), pp.1287~1291 (2006)
- 김함겸, "MRI와 MRA를 이용한 허혈성 뇌혈관 질환의 뇌혈관별 분포에 대한 연구", 방사선기술과학, 33(3), pp.223~230 (2010), 대한방사선과학회
- Arenillas JF, "Intracranial atherosclerosis: current concepts", Stroke, 42(1), pp.S20~S23 (2011)
- 이정훈, "인공 무릎관절에서 자화율 인공물의 감소를 위한 O-MAR XD 기법의 평가", 방사선기술과학, 41(5), pp.413~419 (2018), 대한방사선과학회[DOI]
- Tang CW, "Stenting versus medical treatment for severe symptomatic intracranial stenosis", AJNR, 32(5), pp.911~916 (2011)
- Mazighi M, "Prospective study of symptomatic atherothrombotic intracranial stenoses : the gesica study", Neurology, 66(8), pp.1187~1191 (2006)
- Samuels OB, "A standardized method for measuring intracranial arterial stenosis", AJNR Am J Neuroradiol, 21(4), pp.643~646 (2000)
- SUH, Sang Il, "Guideline for Extracranial Carotid Stenting : Preliminary Report", Neurointervention, 2(1), pp.24~29 (2007)
- Huang J, "Comparison of NASCET and WASID criteria for the measurement of intracranial stenosis using digital subtraction and computed tomography angiography of the middle cerebral artery", J Neuroradiol, 39(5), pp.342~345 (2012)
- Bash S, "Intracranial vascular stenosis and occlusive disease : Evaluation with ct angiography, mr angiography, and digital subtraction angiography", Am J Neuroradiol, 26(5), pp.1012~1021 (2005)
- Chen, L, "Reproducibility of middle cerebral artery stenosis measurements by DSA: Comparison of the NASCET and WASID methods", PloS one, 10(6), pp.e0130991~ (2015)
- Fox AJ, "How to measure carotid stenosis", Radiology, 186(2), pp.316~318 (1993)
- Turan TN, "Risk factors associated with severity and location of intracranial arterial stenosis", Stroke, 41(8), pp.1636~1640 (2010)
- Carvalho M, "Intracranial arterial stenosis", J Stroke Cerebrovasc Dis, 23(4), pp.599~609 (2014)
- Eliasziw M, "Barnett HJ. Further comments on the measurement of carotid stenosis from angiograms. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group", Stroke, 25(12), pp.2445~2449 (1994)
- Zhu XJ, "Morphologic characteristics of atherosclerotic middle cerebral arteries on 3T high-resolution MRI", AJNR Am J Neuroradiol, 34(9), pp.1717~1722 (2013)